Literature DB >> 17147919

Effect of interaction between left ventricular dysfunction and endothelial function in hypertension.

Angela Sciacqua1, Francesco Borrello, Marco Vatrano, Rosa Daniela Grembiale, Francesco Perticone.   

Abstract

Hypertension, one of the most important risk factors for cardiovascular diseases, is associated with both left ventricular hypertrophy and endothelial dysfunction. Both have been recently recognized as independent predictors of clinical events in different groups of patients. In fact, a dysfunctioning endothelium loses its antiatherosclerotic and antithrombotic action, and, therefore, promotes the atherosclerotic process. Similarly, cardiac hypertrophy is recognized as a powerful and independent risk factor for cardiovascular morbidity and mortality because it predisposes to arrhythmias and maximizes the consequences of acute myocardial ischemia. Recently, an evident interaction has been demonstrated between endothelial dysfunction and left ventricular mass. In particular, the coexistence of both left ventricular hypertrophy and endothelial dysfunction almost doubles the risk for future vascular events in hypertensives. Thus, in hypertensive patients, it is clinically useful to choose an aggressive therapeutic strategy--to reduce left ventricular mass and to improve endothelial function.

Entities:  

Mesh:

Year:  2006        PMID: 17147919     DOI: 10.1007/s11906-006-0053-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  45 in total

Review 1.  The clinical implications of endothelial dysfunction.

Authors:  Michael E Widlansky; Noyan Gokce; John F Keaney; Joseph A Vita
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Prognostic significance of endothelial dysfunction in hypertensive patients.

Authors:  F Perticone; R Ceravolo; A Pujia; G Ventura; S Iacopino; A Scozzafava; A Ferraro; M Chello; P Mastroroberto; P Verdecchia; G Schillaci
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

3.  Relation of left ventricular diastolic properties to systolic function in arterial hypertension.

Authors:  G de Simone; R Greco; G Mureddu; C Romano; R Guida; A Celentano; F Contaldo
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

4.  Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; T Gordon; W P Castelli; J R Margolis
Journal:  Ann Intern Med       Date:  1970-06       Impact factor: 25.391

5.  Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients.

Authors:  F Perticone; R Maio; R Ceravolo; C Cosco; C Cloro; P L Mattioli
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

6.  Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy.

Authors:  P Verdecchia; G Schillaci; C Borgioni; A Ciucci; R Gattobigio; I Zampi; A Santucci; C Santucci; G Reboldi; C Porcellati
Journal:  Am J Cardiol       Date:  1996-07-15       Impact factor: 2.778

7.  Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.

Authors:  Francesco Perticone; Angela Sciacqua; Raffaele Maio; Maria Perticone; Renke Maas; Rainer H Boger; Giuseppe Tripepi; Giorgio Sesti; Carmine Zoccali
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

8.  Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women.

Authors:  Maria G Modena; Lorenzo Bonetti; Francesca Coppi; Francesca Bursi; Rosario Rossi
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

9.  Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy.

Authors:  F H Messerli; H O Ventura; D J Elizardi; F G Dunn; E D Frohlich
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

10.  Which definition for echocardiographic left ventricular hypertrophy?

Authors:  E Abergel; M Tase; J Bohlender; J Menard; G Chatellier
Journal:  Am J Cardiol       Date:  1995-03-01       Impact factor: 2.778

View more
  3 in total

1.  VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

Authors:  J Ruth Wu-Wong; Megumi Kawai; Yung-Wu Chen; Masaki Nakane
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

2.  The Potential Role of Circulating Endothelial Cells and Endothelial Progenitor Cells in the Prediction of Left Ventricular Hypertrophy in Hypertensive Patients.

Authors:  Magdalena Budzyń; Bogna Gryszczyńka; Maciej Boruczkowski; Mariusz Kaczmarek; Beata Begier-Krasińska; Angelika Osińska; Alicja Bukowska; Maria Iskra; Magdalena Paulina Kasprzak
Journal:  Front Physiol       Date:  2019-08-09       Impact factor: 4.566

3.  Mechanistic analysis for time-dependent effects of cinacalcet on serum calcium, phosphorus, and parathyroid hormone levels in 5/6 nephrectomized rats.

Authors:  J Ruth Wu-Wong; Masaki Nakane; Yung-Wu Chen; Masahide Mizobuchi
Journal:  Physiol Rep       Date:  2013-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.